15976551

Potdar N

2005

The endocrinological basis of recurrent miscarriages.

15982547

Brown JT

2005

Anabolic steroids: what should the emergency physician know?

15983348

Bloomgarden ZT

2005

Second World Congress on the Insulin Resistance Syndrome: mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy.

15985479

Gonz?lez F

2005

Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.

15985492

Kravariti M

2005

Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.

15987930

Braillon A

2005

Polycystic ovary syndrome.

15989985

Esmailzadeh S

2005

Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology.

15991359

Mikhail E

2005

Polycystic ovary syndrome.

15991360

Mascitelli L

2005

Polycystic ovary syndrome.

15991679

Petr?nyi G

2005

[Treatment experience with metformin in polycystic ovary syndrome].

15992389

Freeman MP

2005

Bipolar disorder in women: reproductive events and treatment considerations.

15994628

Dokras A

2005

Screening women with polycystic ovary syndrome for metabolic syndrome.

15994753

Tarkun I

2005

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.

15994846

Diamanti-Kandarakis E

2005

Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.

16002415

Puder JJ

2005

Letter re: The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.

16006454

Penna IA

2005

Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study.

16006474

Jonard S

2005

Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries.

16006478

Messinis IE

2005

Ovulation induction: a mini review.

16006724

Dereli D

2005

Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease.

16008040

Brandsma I

2005

[Laparoscopic electrocoagulation of the ovaries prior to in vitro fertilization in two females with polycystic ovary syndrome].

16008889

Li Y

2005

[In vitro maturation and fertilization of oocytes from unstimulated cycles in women with infertility due to polycystic ovary syndrome].

16010777

Turner MJ

2005

Metformin: an advance in ovulation induction.

16011474

Cruz ML

2005

Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.

16012604

C?rdova-Fraga T

2004

The colon transit time in different phases of the menstrual cycle: assessed with biomagnetic technique.

16019354

Penezi? Z

2005

Gonadotropin pulsatility in Cushing's syndrome compared with polycystic ovary syndrome.

16019362

Gadducci A

2005

Polycystic ovary syndrome and gynecological cancers: is there a link?

16019367

To WW

2005

A comparison of bone mineral density in oligomenorrhoeic adolescents with polycystic ovaries and normal ovaries.

16019370

Yilmaz M

2005

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.

16019381

Torgac M

2005

Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome?

16021519

Wang L

2005

A two-dimensional electrophoresis reference map of human ovary.

16028378

Pekhlivanov B

2005

[Metformin for the treatment of polycystic ovary syndrome].

16030171

Stubbs SA

2005

Anti-m?llerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.

16030174

Welt CK

2005

Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

16033996

Imamov O

2005

Estrogen receptor beta in health and disease.

16034717

Hahn S

2005

Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.

16034856

Farquhar C

2005

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

16036198

Kaya H

2005

Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.

16037106

Villuendas G

2005

Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls.

16037109

Lakhani K

2005

Microvascular dysfunction in women with polycystic ovary syndrome.

16037412

Panidis D

2005

Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.

16038826

Bodurka DC

2005

What's new in gynecology and obstetrics.

16043756

Escobar-Morreale HF

2005

Body iron stores are increased in overweight and obese women with polycystic ovary syndrome.

16045937

James WH

2006

Possible constraints on adaptive variation in sex ratio at birth in humans and other primates.

16046590

Meyer C

2005

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.

16051336

Schmeler KM

2005

Endometrial cancer in young, normal-weight women.

16076921

Christy NA

2005

Spironolactone for hirsutism in polycystic ovary syndrome.

16076939

Johnsen S

2005

Absence of polycystic ovary syndrome features in human immunodeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity.

16076946

Glintborg D

2005

Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.

16083511

Parsanezhad ME

2005

Hyperprolactinemia after laparoscopic ovarian drilling: an unknown phenomenon.

16083532

Dawber RP

2005

Guidance for the management of hirsutism.

16084882

Dilek S

2005

Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome.

16084883

Carmina E

2005

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.

16084884

Bayram N

2005

Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.

16084891

Yanaihara A

2005

Strong expression of steroid sulfatase in human cumulus cells in patients with endometriosis.

16084906

Panidis D

2005

Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome.

16085166

Buggs C

2005

Polycystic ovary syndrome in adolescence.

16085167

Hillard PJ

2005

Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.

16085666

Vrb?kov? J

2005

Metabolic syndrome in young Czech women with polycystic ovary syndrome.

16086052

Zhao SY

2005

[Protein expression profilings of polycystic ovary syndrome].

16091483

White PC

2005

Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.

16091490

Urbanek M

2005

Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2.

16092652

Raja A

2005

Presentation of polycystic ovary syndrome and its management with clomiphene alone and in combination with metformin.

16095537

Zargar AH

2005

Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus.

16102886

Walch K

2005

A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome.

16103714

Miller WL

2005

Disorders of androgen synthesis--from cholesterol to dehydroepiandrosterone.

16105965

Puder JJ

2005

Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.

16108473

Hoo P

2005

The patient with polycystic ovary syndrome.

16109599

Unfer V

2005

Different routes of progesterone administration and polycystic ovary syndrome: a review of the literature.

16113040

Naz RK

2005

Recent advances in contraceptive vaccine development: a mini-review.

16115348

Marsh K

2005

The optimal diet for women with polycystic ovary syndrome?

16116971

Lv L

2005

Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome.

16116976

Tan L

2005

Role of the pentanucleotide (tttta)n polymorphisms of Cyp11alpha gene in the pathogenesis of hyperandrogenism in Chinese women with polycystic ovary syndrome.

16117910

Svendsen PF

2005

[Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].

16118336

Orio F Jr

2005

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.

16119083

Valueva LG

2003

[Effects of metformin on endocrine parameters and reproductive function in women with polycystic ovary syndrome].

16123051

Heijnen EM

2006

A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.

16123091

Yilmaz M

2005

The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.

16123235

Rulli SB

2005

What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?

16123519

Vaughan TB

2005

Stockpiling of ovarian follicles and the response to rosiglitazone.

16126442

Gervaise A

2005

[Ovarian drilling for treatment of polycystic ovary syndrome].

16128250

Styne DM

2005

Review of the 2nd Annual World Congress on the Insulin Resistance Syndrome.

16129615

van Santbrink EJ

2005

Patient-tailored conventional ovulation induction algorithms in anovulatory infertility.

16129944

Iborra A

2005

Oxidative stress and autoimmune response in the infertile woman.

16130192

Lu XE

2005

Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.

16131582

Seto-Young D

2005

Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production.

16140452

Ng EH

2006

Are there differences in ultrasound parameters between Chinese women with polycystic ovaries only and with polycystic ovary syndrome?

16144493

Schultze-Mosgau A

2005

New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists.

16146570

Stener-Victorin E

2005

Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity.

16147598

Lakhani K

2004

Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.

16147608

El-Sheikhah A

2004

The extent of ovarian damage produced by ovarian cauterisation in the human.

16147649

Resch M

2004

Bulimia from a gynecological view: hormonal changes.

16147697

Qublan HS

2005

Metformin in the treatment of clomiphene citrate-resistant women with high BMI and primary infertility: clinical results and reproductive outcome.

16148382

Gogokhiia NA

2005

[Study of dopamine effect on neuroendocrine disorders during polycystic-ovary syndrome using the method of enzyme-linked immunosorbent analysis (ELISA)].

16149485

Sakata M

2005

[Luteinizing hormone].

16149487

Irahara M

2005

[Gonadotropin releasing hormone (GnRH)].

16149522

Goto K

2005

[DHEA, DHEA-S].

16149526

Kashiwagi B

2005

[Androstenedione].

16149527

Shibata Y

2005

[Androsterone].

16149554

Yamoto M

2005

[Inhibin].

16151492

Ekerhovd E

2005

[Polycystic ovary syndrome].